JWH-250 is a synthetic cannabinoid that belongs to the aminoalkylindole family. It was initially developed by John W. Huffman and his team in the mid-1990s as part of research into the endocannabinoid system. JWH-250 is known for its high affinity for the CB1 receptor, which is the same receptor that the natural cannabinoids in cannabis act upon to produce their effects.